Alleyba says..............
...........that you carefully have to analyze what is happening here. Heavy volume because people with paper, which they are entitled to do because they took risk in lending SCRC money made their profit, got back their investment and have moved on. Do I agree? No because I think their selling was premature given the plans the CEO has for this company.
Logic and previous news releases have said SCRC is undertaking entry into the China market which will be very lucrative if done the right way.Therefore one would expect an update on this sooner than later.Secondly, we should be updated on the status of the Rapimeds launch because that is only logical off of prior news releases.The expectation in my mind domestically should be 6-8 weeks and maybe sooner internationally. Third, there was an increase on the cooperative numbers from TN. which is another good stream of income.
Fourth, the purchase of PIMD, which generates and will incorporate $1,000-$5,000,000 as per their web site to SCRC bottom line will help us reduce packaging and distribution costs thereby increasing profit margins, not to mention the centralized location of the plant for shipping purposes.
Fifth, the CEO announces in 8-K plan to obtain licenses in Florida for "controlled substances" so I logically interpret that as saying he wants to distribute hypothetically since I take it, Ambien or it's generic Zoldipam. Think of those potential revenues.
CEO did what was necessary to make his vision a reality. Was there paper? Yes. Were some of the deals the best deals? No, because his goal was to make this company a real company. He needed financing in order to move forward so sometimes you have to take what you can get. With GEM on board with a presence in 65 countries it legitimizes SCRC. Now our CEO is in a position where he has more leverage and hence can make better deals. He has done his best to take out the paper and not dilute this company. I think he is for the shareholders and wants us all to succeed. THIS IS A REAL COMPANY.
This IS NOT a mining company needing financing to take gold out from the mines. THIS IS NOT A COMPANY with a drug that needs financing for FDA approval.WE ALREADY HAVE THE PRODUCT, THE FINANCING AND THE PLANS IN PLACE. The shareholders who have patience and remain long will be rewarded. This is the 2014 stock of the year that will blow away 2013 revenues in my opinion
